A New Nrf2 and Diabetes Study Underway
To be more specific regarding protecting the heart, this project investigates the effects of NRF2 on diabetic myocardial complications (diabetic cardiomyopathy).  When the results are presented, there will be an answer to whether Nrf2 is capable of preventing diabetes-induced oxidative and nitrosative stress and the resulting progression of diabetic cardiomyopathy.
Diabetes Nrf2

The American Diabetes Journal has details on an interesting NRF2 study currently in progress. Diabetes is a huge concern to many individuals and families. According to statistics published by the American Diabetes Association more than 25.8 million children and adults in the United States in 2010 have diabetes. That accounts for 8.3% of the population. A whopping 79 million people have pre-diabetic symptoms. In 2010, there were 1.9 million new cases of diabetes in people aged 20 years and older.


Complications from Diabetes

The following complications may occur as a result of diabetes.

  • Heart disease and stroke
  • High blood pressure
  • Blindness
  • Kidney disease
  • Nervous system disease (Neuropathy)
  • Amputation


The following study is highlighted on the American Diabetes Association (ADA) website.

Nrf2 activator to prevent diabetic cardiomyopathy

The study is being conducted by: Cai, Lu , M.D., Ph.D. University of Louisville, Louisville, Kentucky. It focuses on both Type 1 And Type 2 Diabetes. The study started January 1, 2011 and is anticipated to end December 31, 2013.

Background:

Oxidative stress is associated with over 200 diseases, including diabetes. A diabetic's heart is easily damaged from oxidative stress. Consuming antioxidants directly is not an effective enough protector of the heart. This study attempts to stimulate the body's own production of several antioxidant genes/proteins in the heart through a pathway known as the Nrf2 pathway. Nrf2 is the master regulator which turns on several antioxidant enzymes in the body.

According to the website, Dr. Cai's group showed that mice without Nrf2 are more easily damaged by diabetes than mice with higher levels of Nrf2. The group used a compound known as Dh404 as their NRF2 activator. Their hope is that results of this study will be conclusive to provide a new medication to protect the heart from diabetes.

The researchers state that although this a new approach to diabetes treatment, their initial research shows it to be "a feasible project since we have shown the importance of Nrf2 in protecting a diabetic heart, and also have the compound (Dh404) to increase cardiac Nrf2 in animals."

To be more specific regarding protecting the heart, this project investigates the effects of NRF2 on diabetic myocardial complications (diabetic cardiomyopathy). When the results are presented, there will be an answer to whether Nrf2 is capable of preventing diabetes-induced oxidative and nitrosative stress and the resulting progression of diabetic cardiomyopathy.

The researchers hope that if their findings are positive, that they might find or develop some dietary supplements to up-regulate cardiovascular levels of Nrf2. They further hope that this NRF2 up-regulation of genes and proteins in the heart will be able to prevent diabetes-induced cardiovascular diseases.

Dr. Cai is motivated to find a cure due to the fact that many of his friends and family have been inflicted with Diabetes, including his mother in 1999 at the age of 59 years of age.

Dr. Cai believes that diabetes (both type I and type II) will be prevented or at least delayed if an early diagnosis and treatment can be implemented as a result of these and future studies. It is his hope that hypertension, cardiomyopathy, and stroke will be prevented through the enhancement of endogenous and exogenous antioxidants.

There are over 150 NRF2/Diabetic studies published on Pubmed.

Sign Up for Our Newsletter



Read More

Oxidative Stress
New Protandim Study – International Formula Impact on Oxidative Stress
There are numerous studies about the USA Protandim formula. This one is about the International formulation.
Augusta Nrf2 Study
Augusta University Discovers How Nrf2 Activator Preserves Sight in Retinal Degeneration Model
“We are very, very pleased that we can now explore the mechanisms,”, mentioned Dr. Sylvia Smith, chair of the Department of Cellular Biology and Anatomy at the Medical College of Georgia at Augusta University and co-director of the James and Jean Culver Vision Discovery Institute at AU.
persistent fibrosis
Reversal of persistent fibrosis in aging by targeting nox4-Nrf2 redox imbalance – Sciencemag.org
This is a promising study because the current treatments of pathological and cystic fibrosis are costly and very time consuming. Persistent fibrosis in lungs of aged mice was caused by the loss of cellular redox balance. The mice in the study with low NRF2 expression had a higher incidence of progressive lung disease. Tissues from human lung samples demonstrated this same Nox4-Nrf2 imbalance.

Next Steps

Get Our Free Newsletter

View Resources

Take Our Quiz

0

PROJECTS COMPLETED

0

ACTIVE CLIENTS

0

CUPS OF COFFEE

0

HAPPY CLIENTS

TESTIMONIALS

What They Say?

SEND US YOUR FEEDBACK

Get a face-to-face appoinment with our qualified specialists

PHONE NUMBER

+ 924 888 0250

EMAIL ADDRESS

hello@spirit.health

OUR LOCATION

Crown Rd. 14b, San Diego, California


© 2021 / Spirit Health / All rights reserved

Malcare WordPress Security